{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:14:07Z","timestamp":1772190847903,"version":"3.50.1"},"reference-count":21,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2025,3,24]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>Patients with cancer are often polysymptomatic due to significant disease and treatment-related morbidity. Vagus nerve stimulation (VNS), a type of neuromodulation, affects various physiological processes that are highly relevant to many cancer-related symptoms. It is an emerging therapy that uses the omnipotent nature of the nerve and is known to ameliorate conditions such as depression, epilepsy, gastrointestinal disorders and migraine. Given the evidence base for VNS and its proven utilisation outside of cancer, we suggest research and clinical application of this treatment modality in supportive oncology.<\/jats:p>","DOI":"10.1136\/spcare-2025-005483","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:20:28Z","timestamp":1746192028000},"page":"328-332","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Vagus nerve and cancer symptom science"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3631-7563","authenticated-orcid":false,"given":"Aynur","family":"Aktas","sequence":"first","affiliation":[{"name":"Department of Supportive Oncology, Atrium Health Levine Cancer Institute, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2904-2752","authenticated-orcid":false,"given":"Dori","family":"Beeler","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Atrium Health Levine Cancer Institute, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jake","family":"Waldman","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Atrium Health Levine Cancer Institute, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Declan","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Supportive Oncology, Atrium Health Levine Cancer Institute, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"2026022702201318000_16.2.328.1","unstructured":"Costanzo LS . Physiology Cases and Problems. 4th ed. Philadelphia: Wolters Kluwer\/Lippincott Williams & Wilkins Health, 2012."},{"key":"2026022702201318000_16.2.328.2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2024.03.005","article-title":"Transcutaneous auricular vagus nerve stimulation for post-stroke depression: A double-blind, randomized, placebo-controlled trial","volume":"354","author":"Liu","year":"2024","journal-title":"J Affect Disord"},{"key":"2026022702201318000_16.2.328.3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.neurom.2021.10.021","article-title":"Comparative Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation vs Citalopram for Major Depressive Disorder: A Randomized Trial","volume":"25","author":"Li","year":"2022","journal-title":"Neuromodulation: Technology at the Neural Interface"},{"key":"2026022702201318000_16.2.328.4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.brs.2012.09.013","article-title":"Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects","volume":"6","author":"Aaronson","year":"2013","journal-title":"Brain Stimul"},{"key":"2026022702201318000_16.2.328.5","doi-asserted-by":"crossref","first-page":"102840","DOI":"10.1016\/j.autneu.2021.102840","article-title":"Transcutaneous vagus nerve stimulation in the treatment of drug-resistant epilepsy","volume":"235","author":"von Wrede","year":"2021","journal-title":"Auton Neurosci"},{"key":"2026022702201318000_16.2.328.6","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001203"},{"key":"2026022702201318000_16.2.328.7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.14309\/ajg.0000000000002548","article-title":"Transcutaneous Auricular Vagal Nerve Stimulation Is Effective for the Treatment of Functional Dyspepsia: A Multicenter, Randomized Controlled Study","volume":"119","author":"Shi","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"2026022702201318000_16.2.328.8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.brs.2019.12.018","article-title":"Non-invasive stimulation of vagal afferents reduces gastric frequency","volume":"13","author":"Teckentrup","year":"2020","journal-title":"Brain Stimul"},{"key":"2026022702201318000_16.2.328.9","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2020-102088"},{"key":"2026022702201318000_16.2.328.10","first-page":"e364","article-title":"Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study","volume":"91","author":"Tassorelli","year":"2018","journal-title":"Neurology (ECronicon)"},{"key":"2026022702201318000_16.2.328.11","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1177\/0333102417742347","article-title":"Peripheral vagal nerve stimulation modulates the nociceptive withdrawal reflex in healthy subjects: A randomized, cross-over, sham-controlled study","volume":"38","author":"De Icco","year":"2018","journal-title":"Cephalalgia"},{"key":"2026022702201318000_16.2.328.12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/03331024211068813","article-title":"Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial","volume":"42","author":"Najib","year":"2022","journal-title":"Cephalalgia"},{"key":"2026022702201318000_16.2.328.13","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1452490","article-title":"Advances in VNS efficiency and mechanisms of action on cognitive functions","volume":"15","author":"Wang","year":"2024","journal-title":"Front Physiol"},{"key":"2026022702201318000_16.2.328.14","unstructured":"Capobianco A . FDA approves first-of-its-kind stroke rehabilitation system. online: food and drug administration; 2021. Available: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-its-kind-stroke-rehabilitation-system [accessed 14 Feb 2025]"},{"key":"2026022702201318000_16.2.328.15","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.brs.2022.10.012","article-title":"Assessment of safety and feasibility of non-invasive vagus nerve stimulation for treatment of acute stroke","volume":"15","author":"Arsava","year":"2022","journal-title":"Brain Stimul"},{"key":"2026022702201318000_16.2.328.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00475-X"},{"key":"2026022702201318000_16.2.328.17","doi-asserted-by":"publisher","DOI":"10.1177\/1545968320924361"},{"key":"2026022702201318000_16.2.328.18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijscr.2020.12.023","article-title":"A case report of Vagus nerve stimulation for intractable hiccups","volume":"78","author":"Tariq","year":"2021","journal-title":"Int J Surg Case Rep"},{"key":"2026022702201318000_16.2.328.19","doi-asserted-by":"crossref","first-page":"19081","DOI":"10.1002\/cam4.6466","article-title":"Putative role of non-invasive vagus nerve stimulation in cancer pathology and immunotherapy: Can this be a hidden treasure, especially for the elderly?","volume":"12","author":"Abdullahi","year":"2023","journal-title":"Cancer Med"},{"key":"2026022702201318000_16.2.328.20","doi-asserted-by":"crossref","first-page":"115836","DOI":"10.1016\/j.bcp.2023.115836","article-title":"Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction","volume":"217","author":"Khuanjing","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"2026022702201318000_16.2.328.21","doi-asserted-by":"crossref","first-page":"20521","DOI":"10.1002\/cam4.6624","article-title":"Neuromodulation as an anticancer strategy","volume":"12","author":"Kumaria","year":"2023","journal-title":"Cancer Med"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-005483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:22:29Z","timestamp":1772187749000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-005483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/spcare-2025-005483"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-005483","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}